MBF Therapeutics Inc

MBF Therapeutics Inc. to Present at Philadelphia PACT Investor Conference

MBF Therapeutics, Inc., a clinical stage animal health company developing checkpoint inhibitor vaccines for cancer and infectious diseases, today announced that Thomas Tillett, Chief Executive Officer, will present at the PACT Capital Conference in Philadelphia, PA on Thursday, November 2, 2017 at... - November 01, 2017